AI in drug development: the FDA needs to set standards - STAT

AI in drug development: the FDA needs to set standards - STAT

Opinion: The FDA needs to set standards for using artificial intelligence in drug development

By CHARLES K. FISHER

DOM SMITH/STAT

As companies apply artificial intelligence to drug development and clinical trials, FDA standards would ease regulatory uncertainty.

READ MORE